The Library
How might remote management of diabetes mellitus during the COVID-19 pandemic impact patient care?
Tools
Barber, Thomas M. and Weickert, Martin O. (2021) How might remote management of diabetes mellitus during the COVID-19 pandemic impact patient care? Expert Review of Endocrinology and Metabolism, 16 (8). pp. 155-158. doi:10.1080/17446651.2021.1947795 ISSN 1744-6651.
|
PDF
WRAP-How-might-remote-management-diabetes-mellitus-2021.pdf - Accepted Version - Requires a PDF viewer. Download (328Kb) | Preview |
Official URL: https://doi.org/10.1080/17446651.2021.1947795
Abstract
The COVID-19 global pandemic has influenced all of our lives to a degree that typically occurs once per century. An event of such magnitude compels us to utilize ‘pre-COVID-19ʹ and ‘post-COVID-19ʹ terminology, analogous to other major global events such as the world wars of the 20th Century. In many ways, the COVID-19 global pandemic has acted like a catalyst for rapid change, and both challenged and enabled changes in our perspectives that would have been inconceivable in the pre-COVID-19 world. Within the healthcare arena, one of the most radical COVID-19-induced changes has been the adoption of remote management practices. This is particularly relevant for patients with long-term chronic conditions such as malignancies [1] and Diabetes Mellitus (DM), that require focused and regular follow-up by healthcare professionals (HCPs) within diverse settings such as out-patient clinics, primary care facilities or within the community. Given the utility of improved glycemic control in patients with DM on reducing the risk for adverse clinical outcomes from COVID-19 [2], it is important to consider the impact on patients with DM from the adoption of remote management practices post-COVID-19. We consider this from both the HCP and patient perspective.
Item Type: | Journal Article | ||||||
---|---|---|---|---|---|---|---|
Subjects: | R Medicine > R Medicine (General) R Medicine > RC Internal medicine |
||||||
Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Biomedical Sciences Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine > Metabolic and Vascular Health (- until July 2016) Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||||
Library of Congress Subject Headings (LCSH): | Diabetes, COVID-19 (Disease) | ||||||
Journal or Publication Title: | Expert Review of Endocrinology and Metabolism | ||||||
Publisher: | Taylor & Francis | ||||||
ISSN: | 1744-6651 | ||||||
Official Date: | 30 June 2021 | ||||||
Dates: |
|
||||||
Volume: | 16 | ||||||
Number: | 8 | ||||||
Page Range: | pp. 155-158 | ||||||
DOI: | 10.1080/17446651.2021.1947795 | ||||||
Status: | Peer Reviewed | ||||||
Publication Status: | Published | ||||||
Reuse Statement (publisher, data, author rights): | “This is an Accepted Manuscript of an article published by Taylor & Francis in Expert Review of Endocrinology and Metabolism on 30/06/2021, available online: http://www.tandfonline.com/10.1080/17446651.2021.1947795 | ||||||
Access rights to Published version: | Restricted or Subscription Access | ||||||
Description: | Free access |
||||||
Date of first compliant deposit: | 26 July 2021 | ||||||
Date of first compliant Open Access: | 30 June 2022 | ||||||
Related URLs: |
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |
Downloads
Downloads per month over past year